White Hickory Allergy Shots (SCIT)
White hickory is a regional common name applied loosely to several Carya species β most often mockernut (Carya tomentosa) β but the immunologic reality is that all Carya species cross-react so completely at the pollen level that the exact species in a SCIT extract rarely matters. No IUIS-named pollen allergen exists for any Carya species, and no SCIT RCT has been conducted for white hickory.
About Curexβs SCIT program
Curexβs at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- β’ Pollens β tree, grass, weed & ragweed
- β’ Pet dander β cat & dog
- β’ Dust mites
- β’ Molds β Alternaria & mold mix
White Hickoryis covered here for general education and may not be part of Curexβs current treatment set. Join the waitlist and our care team will help confirm your options.
White Hickory Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to white hickory β rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of white hickory allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7β10 years.
There are two evidence-based forms of white hickory immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course β the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of white hickory extract in a clinic, escalating over 3β6 months until a maintenance dose is reached. Continued monthly for 3β5 years. Longest clinical track record for white hickory allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50β100+ in-person clinic visits across the full course
- Or at home with no clinic visitsβ Curexβs Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing white hickory extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home β no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription white hickory immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots β protocol, efficacy data, side effects, and cost. If youβd rather skip the clinic and treat white hickory allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is White Hickory?
The biology, taxonomy, and clinical fingerprint of White Hickory β the foundation of how SCIT targets it.
Carya tomentosa (mockernut hickory) is one of the most common eastern US hickories β but 'white hickory' as a common name may refer to several Carya species depending on region. The clinically relevant fact is that all Carya species cross-react at the pollen level, making genus-level sensitization the actionable finding rather than species identification.
- Scientific name
- Carya tomentosa (Lam.) Nutt. (mockernut hickory) and related Carya spp.
- Family
- JuglandaceaeWalnut family
- Type
- Deciduous tree pollen
- Native to
- Eastern and central US β mockernut (C. tomentosa) is one of the most widespread Carya species across the eastern US (USDA PLANTS)
- Allergen proteins
- NO IUIS-named pollen allergen exists for Carya tomentosa or any other Carya species as of May 2026No molecular characterization published for C. tomentosa pollen allergensNamed Carya allergens at WHO/IUIS are all kernel food proteins from pecan (C. illinoinensis): Car i 1 (2S albumin), Car i 2 (vicilin), Car i 4 (11S legumin)No named kernel allergens exist for C. tomentosa specificallyIntra-Carya pollen cross-reactivity is reported as essentially complete in clinical practice
- Particle size
- ~30β45 ΞΌm
- Avoidance difficulty
- Very difficult
How White Hickory Allergy Presents
Symptoms by body system β useful for distinguishing White Hickory sensitivity from overlapping allergies and infections.
Respiratory (Pollen β Inhalant Allergy)
- Sneezing and rhinorrhea during AprilβMay hickory pollen season across the eastern US
- Nasal congestion in areas with dense Carya canopy β mockernut is one of the most common hickories in eastern hardwood forests
- Itchy nasal passages during catkin release, particularly in the Mid-Atlantic and Southeast
- Potential asthma exacerbations in sensitized patients during peak Carya pollen season
- Post-nasal drip and cough from sustained Carya pollen exposure
Ocular
- Bilateral eye itching and watering during AprilβMay Carya pollen season
- Conjunctival redness on high-pollen days in forested areas
- Morning eyelid puffiness from overnight pollen settling in hickory-rich environments
- Photophobia during more severe allergic conjunctivitis episodes
Dermal
- KERNEL DISAMBIGUATION: Hickory kernel food reactions are driven by storage proteins cross-reactive with pecan Car i 1/2/4 β these are NOT treated by hickory pollen SCIT. If you experience systemic reactions to eating hickory nuts, seek evaluation for kernel storage-protein food allergy independently of pollen SCIT.
- Contact dermatitis from hickory tree sap or green hull (separate from pollen allergy)
- Atopic dermatitis flares coinciding with Carya pollen season in susceptible patients
Systemic
- Fatigue from the extended eastern US tree-pollen season, where Carya overlaps with oak and ash in AprilβMay
- Sleep disruption from nasal congestion during peak hickory weeks
- Diagnostic uncertainty β 'white hickory' allergy test reports cause confusion about which Carya species was tested and whether the result reflects pollen, kernel, or genus-level sensitization
- Reduced outdoor activity tolerance during prime spring season in Carya-rich eastern forests
When my patients see 'white hickory' on their allergy test, I have to explain it's usually mockernut, but the immunologic reality is that all Carya species cross-react so completely at the pollen level that the exact species in your extract rarely matters β what matters is whether you live in hickory country and are sensitized to the Carya genus.
When & Where White Hickory Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: AprilβMay across the eastern and central US β same window as other Carya speciesΒ· ~4β6 weeks; overlaps with oak and ash pollen in the eastern hardwood forest
US Exposure Map
7 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- None
- MT:
- None
- ND:
- None
- MN:
- Low
- WI:
- Low
- MI:
- Low
- NY:
- Moderate
- MA:
- Low
- OR:
- None
- ID:
- None
- WY:
- None
- SD:
- None
- IA:
- Low
- IL:
- Moderate
- IN:
- High
- OH:
- High
- PA:
- Moderate
- NJ:
- Moderate
- CT:
- Low
- RI:
- Low
- CA:
- None
- NV:
- None
- UT:
- None
- CO:
- None
- NE:
- Low
- MO:
- Moderate
- KY:
- High
- WV:
- High
- VA:
- High
- MD:
- Moderate
- DE:
- Moderate
- AZ:
- None
- NM:
- None
- KS:
- Low
- AR:
- Moderate
- TN:
- High
- NC:
- High
- SC:
- None
- OK:
- Low
- LA:
- Low
- MS:
- Moderate
- AL:
- Moderate
- GA:
- Moderate
- TX:
- Low
- FL:
- Low
- AK:
- None
- HI:
- None
What White Hickory Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
White hickory pollen cross-reactivity follows the Carya genus pattern β essentially complete within the genus via shared but uncharacterized pollen proteins, and moderate-to-high with Juglans (walnut) at the family (Juglandaceae) level. No molecular characterization exists for C. tomentosa pollen proteins.
Within-Carya genus; Hoffman 1996 and Bucholtz series show 27% sensitization to pecan/hickory combined
Kernel storage-protein cross-reactivity with pecan Car i 1/2/4 and walnut Jug r 1/2/4 β NOT treated by pollen SCIT
Is SCIT Right for Your White Hickory Allergy?
Answer five questions to assess whether Carya genus-level SCIT (including white hickory) is appropriate for your spring tree allergy.
How severe are your spring symptoms during AprilβMay hickory pollen season in the eastern US?
The White Hickory SCIT Protocol
White hickory SCIT uses non-standardized Carya extract β which in practice is often a pecan or hickory-pecan mix formulation rather than a C. tomentosa-specific extract. Because intra-Carya cross-reactivity is essentially complete, the genus-level extract provides equivalent clinical coverage regardless of which Carya species is labeled on the vial.
Injections begin at 1:100,000 w/v β Curex's conservative starting dilution β and increase incrementally. Eastern US patients should ideally start build-up in fall or winter β before the April Carya pollen season β to avoid elevated reactivity from active pollen co-exposure during titration. Patients with hickory kernel food allergy must continue strict kernel avoidance and carry an epinephrine auto-injector. With at-home SCIT through Curex, the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff, with a prescribed epinephrine auto-injector confirmed on hand and a 30-minute self-observation after each injection.
Ongoing maintenance sustains Carya genus-level tolerance. White hickory is typically included in a broader Juglandaceae-anchored or eastern tree-mix, often alongside pecan and other Carya species.
Lasting benefit expected with full course completion. SCIT discontinuation has no impact on hickory kernel food allergy management.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for White Hickory SCIT
White hickory pollen SCIT has no species-specific RCT and no formally named pollen allergen. Efficacy is extrapolated from general Carya genus-level evidence, which itself rests on observational sensitization data rather than controlled immunotherapy trials.
- Carya/hickory sensitization in NYC tree-allergic patients27%Bucholtz et al. NYC series β 27.1% of 371 tree-allergic patients reacted to pecan/hickory pollen
- General inhalant SCIT efficacy for non-standardized tree pollens55%Cox L et al., J Allergy Clin Immunol 2011 β AAAAI Practice Parameter general evidence framework
White hickory SCIT has no direct efficacy evidence. All clinical use is based on the genus-level Carya evidence (Hoffman 1996, Bucholtz series sensitization data) and the general inhalant SCIT evidence framework. The clinically actionable insight is that intra-Carya cross-reactivity is essentially complete β so the specific Carya species in the extract is less important than confirming Carya genus-level sensitization and including an appropriate Carya component in the patient's regional tree mix.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
White Hickory SCIT Side Effects
White hickory SCIT side effects follow the standard inhalant SCIT profile with no species-specific differences from other Carya extracts.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Expected during build-up; resolves within 24 hours | Rate 30β50% | Mild |
Injection-site itching Ice and pre-treatment antihistamine recommended | Rate 20β40% | Mild |
Large local reaction (>25 mm) Higher during active Carya pollen season; fall/winter start preferred | Rate 5β10% | Moderate |
Persistent redness Resolves within 24 hours in most cases | Rate 10β20% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis/conjunctivitis flare Sneezing or eye watering within minutes to 1 hour; antihistamine responsive | Rate 0.5β1% | Mild |
Urticaria Generalized hives; managed with antihistamines Β± epinephrine | Rate 0.1β0.5% | Moderate |
Bronchospasm Higher risk in asthmatic patients; spirometry before SCIT recommended | Rate 0.1β0.3% | Moderate |
Anaphylaxis Rare at properly titrated doses; a prescribed epinephrine auto-injector is confirmed on hand and a 30-minute self-observation follows every dose; for at-home SCIT through Curex the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff | Rate <0.01% | Severe |
CRITICAL: Patients with confirmed hickory or pecan kernel food allergy (Car i 1/2/4-driven) must continue strict kernel avoidance and carry an epinephrine auto-injector regardless of pollen SCIT status. Pollen SCIT does not desensitize kernel storage-protein food allergy. A 30-minute self-observation follows every dose; with at-home SCIT through Curex the serum is sterile-compounded to USP <797>, a prescribed epinephrine auto-injector is confirmed on hand, and the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff.
SCIT vs Alternatives for White Hickory
Patients sensitized to white hickory / Carya genus have four main options: Carya-anchored SCIT (including white hickory in an eastern tree mix), at-home sublingual drops, avoidance in Carya-rich environments, and daily seasonal medications.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Uncertain β no white-hickory-specific RCT; genus-level Carya evidence from Hoffman 1996 and Bucholtz series | Uncertain β no hickory pollen SLIT RCT; off-label drops available | Low β Carya is widespread in eastern US forests and suburban landscapes | Moderate β antihistamines + nasal corticosteroids for mild-to-moderate symptoms |
| 5-yr cost | $3,500β$15,000 over 5 years | Available from various providers as off-label sublingual drops (not Curex's product β Curex delivers at-home SCIT shots, not drops) | Low β HEPA, pollen masks, closed windows during AprilβMay | $500β$2,000 over 5 years |
| Duration | 3β5 year course | 3β5 year course | Indefinite β no tolerance change | Indefinite β seasonal use |
| Convenience | Weekly at-home self-injection with Curex; fall/winter start preferred; the first injection from each new vial or concentration supervised live in the Virtual Shot Room | Daily at-home β no clinic required | Moderate inconvenience during spring | High convenience |
| Safety | Excellent with a prescribed epinephrine auto-injector on hand, a 30-min self-observation, and live Zoom supervision of every dose change | Favorable for pollen inhalant; does not affect kernel food allergy risk | Safe | Generally safe |
| Lasting effect | 7β12+ years after completion | Emerging data | None β symptoms return each April | None β must take every season |
SCITBest
SLIT
Avoidance
Medications
SCIT including Carya genus-level extract is the standard approach for white hickory allergy, exploiting the near-complete intra-genus cross-reactivity to cover all regional Carya species in a single extract component. Curex now offers this as a weekly at-home allergy shot with pricing confirmed in a current program quote, with a serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first injection from each new vial or concentration supervised live in the Virtual Shot Room by trained Curex clinical staff. Sublingual drops remain a general allergy modality some providers offer for patients who prefer a needle-free option.
What White Hickory SCIT Actually Costs
White hickory / Carya SCIT is covered by most major US insurers under standard allergy immunotherapy benefits when prescribed by a board-certified allergist with documented sensitization. White hickory is typically billed as part of a multi-species eastern tree mix rather than as a standalone extract. Curex at-home IgE testing identifies specific white hickory sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your white hickory allergy. Get a plan.
Take Curexβs 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you β shots or drops.
Free quiz Β· Board-certified allergists Β· 50,000+ patients treated Β· HSA/FSA eligible
White Hickory SCIT β Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
White hickory is a regional common name that can refer to several Carya species depending on where you live. Most commonly, it refers to mockernut hickory (Carya tomentosa) β one of the most widespread hickories in the eastern US. In some regions, it may refer to bitternut (C. cordiformis) or even shagbark (C. ovata). Because intra-Carya pollen cross-reactivity is essentially complete, the specific Carya species labeled on your allergy test result rarely changes the clinical decision β what matters is whether you are Carya genus-sensitized and whether that sensitization is driving significant spring symptoms. Ask your allergist which species was used in the skin test and what regional Carya species are dominant in your environment.
Functionally yes, at the pollen level. Intra-Carya pollen cross-reactivity is reported as essentially complete in clinical allergy practice β meaning patients sensitized to one Carya species typically react equally to all others. White hickory (mockernut) and shagbark hickory (Carya ovata) share the same genus and the same uncharacterized pollen protein family. The clinical distinction between these species matters for pollen-count studies β shagbark is ranked as the most allergenic Carya in classical pollen-count studies β but for SCIT extract selection, a single Carya preparation (typically pecan or hickory-pecan mix) provides equivalent genus-level coverage without needing to include every hickory species separately.
No β they are entirely different conditions. Hickory kernel food allergy is driven by heat-stable storage proteins cross-reactive with pecan Car i 1 (2S albumin), Car i 2 (vicilin), and Car i 4 (11S legumin). These proteins can cause systemic reactions including anaphylaxis when eating hickory or pecan kernels, and the primary management is strict kernel avoidance plus an epinephrine auto-injector β immunotherapy for the food allergy is not standard practice. Hickory pollen allergy is an inhalant allergy causing rhinitis and conjunctivitis during AprilβMay catkin release, and can potentially be treated by SCIT. The pollen extract used in SCIT contains pollen proteins, not kernel storage proteins β so pollen SCIT does not desensitize the kernel food allergy in any way.
A Carya genus-level test β using pecan or hickory-pecan extract, which are the best-characterized available preparations β is generally sufficient for clinical purposes. Because intra-Carya cross-reactivity is essentially complete, a positive result to any Carya species extract reliably predicts reactivity to the others. White-hickory-specific skin test extracts are available from some US extract manufacturers, but the clinical information added beyond a pecan or hickory-pecan test is minimal. Component-resolved blood testing for Car i 1, Car i 2, and Car i 4 helps distinguish kernel food allergy from pollen allergy but tests kernel proteins, not pollen-specific proteins.
Yes β hickory species, including mockernut (C. tomentosa), are abundant in the Mid-Atlantic hardwood forest ecosystem (Virginia, West Virginia, Maryland, Pennsylvania, New Jersey), and Carya pollen is a documented contributor to spring rhinitis across this region. The Bucholtz NYC series showed 27.1% reactivity to pecan/hickory pollen among 371 tree-allergic patients β a North Atlantic population that demonstrates Carya sensitization extends well beyond the South-Central pecan belt. Shagbark hickory (C. ovata) is particularly concentrated in the Mid-Atlantic and has been ranked as the most allergenic Carya species in classical pollen-count studies, though all Carya cross-react equivalently at the immunotherapy level.
Rarely. Because intra-Carya pollen cross-reactivity is essentially complete, your allergist will almost always include Carya genus-level extract (typically pecan or hickory-pecan mix) in your regional tree-mix preparation rather than adding a separate white-hickory-only vial. Adding individual Carya species separately would not provide meaningfully broader coverage β it would simply dilute the overall extract volume available for the other clinically important allergens in your regional tree mix. If your skin test shows significant Carya reactivity and you have prominent spring symptoms in the Carya season, the standard approach is to ensure an adequate dose of the Carya-mix component in your overall tree-mix extract.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs β including the parts that are not flattering.